Role of Epidermal Growth Factor Receptor Signaling Pathway in Progestin Resistance of Human Endometrial Carcinoma Xenografts
XU Yan-li,WANG Juan,AI Zhi-hong,TENG Yin-cheng
DOI: https://doi.org/10.3969/j.issn.1674-8115.2011.01.005
2011-01-01
Abstract:Objective To establish progestin-resistant models of human endometrial carcinoma xenografts,and explore the role of epidermal growth factor receptor(EGFR) signaling pathway in progestin resistance of human endometrial carcinoma xenografts.Methods Thirty-six nude mice were subcutaneously injected with human endometrial carcinoma progestin-sensitive Ishikawa cells(n=18) or progestin-insensitive Ishikawa-pLWERNL cells(n=18),and human endometrial carcinoma xenografts were formed.Then,both nude mice treated with Ishikawa cells and Ishikawa-pLWERNL cells were divided into three groups,respectively(n=6),and were managed with medroxyprogesterone acetate(MPA)(MPA group),gefitinib(gefitinib group) and normal saline(control group),respectively.After treatment,wet weight of xenografts was recorded,and the expression of EGFR,progesterone receptor B(PR-B),ERK1/2,p-ERK1/2,AKT and p-AKT protein in xenograft tissues was detected by Western blotting.Results In nude mice treated with Ishikawa cells,the wet weight of xenografts in MPA group and gefitinib group was 43.0% and 31.5% lower than that in control group,respectively(P0.05).In nude mice treated with Ishikawa-pLWERNL cells,the wet weight of xenografts in gefitinib group and MPA group was 35.7% and 2.9% lower than that in control group,respectively(P0.05 and P0.05).The expression of EGFR protein in xenograft tissues treated with Ishikawa-pLWERNL cells was significantly higher than that in xenograft tissues treated with Ishikawa cells(P0.05),while that was opposite for the expression of PR-B protein(P=0.000).In xenograft tissues treated with Ishikawa cells,the expression of PR-B protein in MPA group was significantly lower than that in control group(P0.01),while there was no significant difference between gefitinib group and control group(P0.05).In xenograft tissues treated with Ishikawa-pLWERNL cells,there was no significant difference in the expression of PR-B protein among groups(P0.05).In xenograft tissues treated with Ishikawa cells,the expression of p-ERK1/2 and p-AKT protein in gefitinib group was significantly lower than that in control group and MPA group(P0.05).In xenograft tissues treated with Ishikawa-pLWERNL cells,the expression of p-ERK1/2 and p-AKT protein in gefitinib group was significantly lower than that in control group(P0.05),and the expression of p-ERK1/2 and p-AKT protein in MPA group was significantly higher than that in control group(P0.01).Conclusion The over-expressed EGFR protein can downregulate the expression of PR-B protein in Ishikawa-pLWERNL xenografts,which results in insensitivity to MPA.Gefitinib,the EGFR tyrosine kinase inhibitors,can effectively inhibit the expression of p-ERK1/2 and p-AKT protein,especially in progestin-insensitive Ishikawa-pLWERNL xenografts.